| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 0.30 |
—
—
—
|
| 2025 | 0.36 |
—
—
—
—
—
|
| 2024 | 0.32 |
—
—
—
—
—
|
| 2023 | 0.28 |
—
—
—
—
|
| 2022 | 0.28 |
—
—
—
—
—
|
| 2021 | 0.24 |
—
—
—
—
|
| 2020 | 0.16 |
—
—
—
—
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2016 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 167.59 | 183.70 | 113.74 | 110.12 |
| Receivables | 17.73 | 23.74 | 13.80 | 19.57 |
| Inventory | 30.71 | 28.37 | 30.41 | 31.76 |
| Other | — | — | — | — |
| 218.26 | 237.96 | 159.90 | 163.63 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 3.15 | 3.76 | 2.70 | 3.95 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 30.45 | 91.06 | 20.58 | 18.13 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 40.57 | 43.61 | — | — |
—
|
| ’25 | 40.27 | 40.37 | 39.95 | 37.70 |
158.29
|
| ’24 | 37.97 | 35.89 | 33.67 | 38.42 |
145.94
|
| ’23 | 41.15 | 36.62 | 40.36 | 43.17 |
161.29
|
| ’22 | 42.05 | 41.68 | 42.86 | 39.97 |
166.56
|
| ’21 | 35.92 | 36.25 | 34.56 | 34.08 |
140.82
|
| ’20 | 32.31 | 23.80 | 28.43 | 30.00 |
114.54
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (3.54) | 10.97 | — | — |
—
|
| ’25 | (47.47) | 7.29 | 7.94 | (4.15) |
(36.40)
|
| ’24 | 6.74 | 15.53 | (5.68) | 8.98 |
25.57
|
| ’23 | 7.28 | 13.65 | (5.46) | 21.54 |
37.00
|
| ’22 | 3.00 | 10.63 | (0.89) | 14.20 |
26.93
|
| ’21 | 2.08 | 11.54 | (3.35) | 7.35 |
17.61
|
| ’20 | 3.59 | 8.53 | (2.96) | 9.87 |
19.02
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (3.95) | 9.85 | — | — |
—
|
| ’25 | (48.30) | 5.94 | 6.95 | (4.75) |
(40.15)
|
| ’24 | 6.44 | 15.11 | (6.15) | 13.74 |
29.14
|
| ’23 | 7.01 | 13.44 | (5.55) | 20.97 |
35.87
|
| ’22 | 1.28 | 10.13 | (1.68) | 13.51 |
23.24
|
| ’21 | 1.51 | 10.51 | (4.02) | 5.52 |
13.52
|
| ’20 | 3.23 | 8.03 | (3.39) | 9.42 |
17.28
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.09 | 0.18 | — | — |
—
|
| ’25 | 0.01 | 0.01 | (0.16) | (0.63) |
(0.77)
|
| ’24 | 0.14 | 0.16 | 0.74 | 0.34 |
1.38
|
| ’23 | (0.14) | (0.06) | 0.00 | 0.16 |
(0.05)
|
| ’22 | 0.38 | 0.62 | (0.18) | (0.13) |
0.69
|
| ’21 | 0.27 | 0.26 | 0.21 | 0.31 |
1.05
|
| ’20 | 0.04 | 0.09 | 0.08 | 0.09 |
0.30
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.54 | 4.46 | 5.00 | 5.04 | — | — | — |
Low Price
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡ | 10.71 | 7.64 | 9.42 | 9.27 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 609 | 555 | 510 | 549 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.27 | 0.29 | 0.29 | 0.29 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 166.56 | 161.29 | 145.94 | 158.29 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.30% | 30.52% | 28.34% | 30.44% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.24 | (6.42) | 83.32 | (51.42) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.56% | (3.98%) | 57.09% | (32.49%) | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.46 | 0.58 | 69.26 | (35.37) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.98 | 3.97 | 3.69 | 3.65 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.41 | 3.30 | 2.99 | 3.24 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 0.69 | (0.05) | 1.38 | (0.77) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 0.55 | 0.76 | 0.52 | (0.75) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.08) | (0.02) | 0.07 | (0.08) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.48 | 0.73 | 0.60 | (0.82) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.25 | 8.02 | 8.52 | 7.71 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 48.81 | 48.83 | 48.84 | 48.86 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.36 | 0.00 | 5.63 | 0.00 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.89 | 1.68 | 2.60 | 1.69 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.78 | 0.69 | 0.91 | 0.71 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 1.04 | 0.64 | 1.35 | 0.97 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.49 | 2.88 | 6.74 | (3.84) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.93 | 37.00 | 25.57 | (36.40) | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.69) | (1.13) | 3.57 | (3.75) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.24 | 35.87 | 29.14 | (40.15) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 161.92 | 187.82 | 146.90 | 139.32 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.50 | 0.50 | 0.50 | 0.50 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (141.40) | (167.09) | (183.20) | (113.24) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 402.75 | 391.76 | 415.90 | 376.79 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.61% | (0.39%) | 11.64% | (7.26%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.28% | 3.93% | 10.17% | 2.53% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.59% | (0.58%) | 16.65% | (9.54%) | — | — | — |
ROE
|
NL Industries (NL), a small-cap holding company with key stakes in titanium dioxide producer Kronos Worldwide and security products firm CompX, exemplifies cyclical resilience amid volatile TiO2 pigment markets. Over the past decade, its stock has swung from lows below $2 to highs above $16, driven by pigment price booms and busts, yet 2024 delivered a sharp turnaround with $1.38 EPS (from near-zero prior year), robust $69 million net income, and steady free cash flow, underscoring operational efficiency despite revenue dips to $146 million.
The balance sheet stands as a fortress: zero meaningful debt, $183 million net cash, and book value per share up 114% to $8.52 since 2016, trading at a dirt-cheap P/E of 5.6 and P/B under 1—rarer than a honest politician. Insider buying in early 2025, including a director’s 13,000-share purchase, signals strong confidence amid mid-single-digit share prices.
Priced for pessimism with TiO2 uncertainty from China oversupply, NL offers compelling upside if markets stabilize—potentially revisiting $9+ highs (50%+ gains)—bolstered by Kronos efficiencies and CompX steadiness. Yet cycles loom as the real risk; this hidden gem demands patience for retail investors eyeing patient capital plays.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.